Regenxbio Cash from Financing (TTM) Analysis

Regenxbio Inc (RGNX)

16.19 +0.13 (+0.81%) USD | NASDAQ | Apr 26, 16:00

16.19 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-34.97M
September 30, 2023	-31.92M
June 30, 2023	-32.54M
March 31, 2023	-31.04M
December 31, 2022	-28.84M
September 30, 2022	-27.54M
June 30, 2022	-24.40M
March 31, 2022	-22.87M
December 31, 2021	195.25M
September 30, 2021	397.03M
June 30, 2021	400.78M
March 31, 2021	408.74M
December 31, 2020	200.21M
September 30, 2020	7.595M
June 30, 2020	7.468M
March 31, 2020	7.01M
December 31, 2019	8.376M

Date	Value
September 30, 2019	12.12M
June 30, 2019	202.60M
March 31, 2019	204.40M
December 31, 2018	204.44M
September 30, 2018	200.90M
June 30, 2018	9.688M
March 31, 2018	17.24M
December 31, 2017	84.60M
September 30, 2017	82.80M
June 30, 2017	82.24M
March 31, 2017	71.62M
December 31, 2016	0.119M
September 30, 2016	-2.25M
June 30, 2016	145.35M
March 31, 2016	213.30M
December 31, 2015	239.31M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-34.97M

Minimum

Dec 2023

408.74M

Maximum

Mar 2021

84.90M

Average

7.468M

Median

Jun 2020

Cash from Financing (TTM) Benchmarks